Lisa Kay, creator and chief executive of Sole Bliss, was among 197 entrepreneurs honoured by the King during an awards ...

The biggest difference between the espadrille and friulane is the sole: Traditionally, espadrilles have a rope sole, whereas ...

Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight loss market. As Reuters reports today, an online weight loss company ...

Wegovy and Ozempic-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity ...

Novo Nordisk, the maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by "mutual agreement" with the company's board of directors, citing "recent market challenges ...

Novo Nordisk confirmed it is now seeking a successor for Jørgensen, but these are big shoes that need filling. As Novo notes, "during his eight-year tenure as CEO, Novo Nordisk's sales ...

Novo Nordisk announced Friday that it would part ways with its longtime CEO, who steered the company into an unprecedented boom time for weight-loss drugs. The Ozempic maker’s chief executive, ...

You can reach Andrew on Signal at drewqjoseph.45. LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of its obesity and diabetes medications to become one of the ...

Despite Novo Nordisk's stock decline, the company's competitive position is strengthening, driven by strong sales growth in Wegovy, Ozempic, and rare diseases. Eli Lilly's oral weight-loss drug ...

Ltd. (Novo Nordisk), a global healthcare company committed to driving change in chronic diseases, has announced the delivery of unique shoes, produced in collaboration with renowned Thai shoe ...

Such good fortune is affecting the companies which make them. Ozempic and Wegovy maker Novo Nordisk this week released its Q1 earnings, and it’s clear that GLP-1s are driving profits. Sales for the ...